Resmed Inc
(RMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 584,376 | 405,364 | 203,613 | 474,505 | 279,405 |
| Depreciation Amortization | 148,834 | 97,225 | 47,619 | 191,518 | 145,839 |
| Accounts receivable | 98,158 | 82,469 | 33,704 | -129,195 | -39,899 |
| Other Working Capital | -517,268 | -383,863 | -329,966 | 1,405 | 28,791 |
| Other Operating Activity | -42,439 | -46,973 | -20,627 | 198,485 | 96,057 |
| Operating Cash Flow | $271,661 | $154,222 | $-65,657 | $736,718 | $510,193 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,812 | -12,364 | -6,600 | -21,788 | -20,038 |
| PPE Investments | -106,192 | -57,747 | -27,340 | -102,712 | -74,805 |
| Net Acquisitions | -35,915 | -35,915 | N/A | -39,067 | -30,704 |
| Purchase Sale Intangibles | -17,449 | -13,737 | -4,453 | -14,114 | -11,149 |
| Other Investing Activity | -22,758 | -19,156 | -7,934 | 5,105 | 15,157 |
| Investing Cash Flow | $-174,677 | $-125,182 | $-41,874 | $-158,462 | $-110,390 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 160,000 | 160,000 | 150,000 | 90,000 | 90,000 |
| Debt Repayment | -136,000 | -136,000 | N/A | -612,000 | -536,000 |
| Common Stock Issued | 26,269 | 23,455 | 4,354 | 37,790 | 18,759 |
| Dividend Paid | -183,853 | -122,434 | -61,189 | -226,713 | -169,917 |
| Other Financing Activity | -52,278 | -50,025 | -195 | -53,709 | -53,438 |
| Financing Cash Flow | $-185,862 | $-125,004 | $92,970 | $-764,632 | $-650,596 |
| Exchange Rate Effect | -4,631 | -4,838 | -4,568 | 18,498 | 18,272 |
| Beginning Cash Position | 295,278 | 295,278 | 295,278 | 463,156 | 463,156 |
| End Cash Position | 201,769 | 194,476 | 276,149 | 295,278 | 230,635 |
| Net Cash Flow | $-93,509 | $-100,802 | $-19,129 | $-167,878 | $-232,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | 271,661 | 154,222 | -65,657 | 736,718 | 510,193 |
| Capital Expenditure | -106,192 | -57,747 | -27,340 | -102,712 | -74,805 |
| Free Cash Flow | 165,469 | 96,475 | -92,997 | 634,006 | 435,388 |